{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:17:55Z","timestamp":1774955875242,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Liaoning Provincial Doctoral Research Startup Fund Project","award":["2022-BS-244"],"award-info":[{"award-number":["2022-BS-244"]}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"crossref","award":["XLYC1907113"],"award-info":[{"award-number":["XLYC1907113"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Distinguished Young Scholars in Dalian","award":["2022RJ19"],"award-info":[{"award-number":["2022RJ19"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45676-x","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:29:49Z","timestamp":1774621789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics and network pharmacology reveal the mechanisms of Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang against pancreatic cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhihao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexue","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruotong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanveer","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyokchol","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"45676_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M. & Maitra, A. Pancreatic cancer: Advances and challenges. Cell 186, 1729\u20131754. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014 (2023).","journal-title":"Cell"},{"key":"45676_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/MPA.0000000000001222","volume":"48","author":"C Zhao","year":"2019","unstructured":"Zhao, C., Gao, F., Li, Q., Liu, Q. & Lin, X. The distributional characteristic and growing trend of pancreatic cancer in China. Pancreas 48, 309\u2013314. https:\/\/doi.org\/10.1097\/MPA.0000000000001222 (2019).","journal-title":"Pancreas"},{"key":"45676_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1158\/1078-0432.CCR-16-2319","volume":"23","author":"GA Manji","year":"2017","unstructured":"Manji, G. A., Olive, K. P., Saenger, Y. M. & Oberstein, P. Current and emerging therapies in metastatic pancreatic cancer. Clin. Cancer Res. 23, 1670\u20131678. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2319 (2017).","journal-title":"Clin. Cancer Res."},{"key":"45676_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2020.101876","volume":"31","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Photodynamic therapy of pancreatic cancer: Where have we come from and where are we going?. Photodiagnosis Photodyn. Ther. 31, 101876. https:\/\/doi.org\/10.1016\/j.pdpdt.2020.101876 (2020).","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"45676_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu, Z. I. & O\u2019Reilly, E. M. Therapeutic developments in pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 21, 7\u201324. https:\/\/doi.org\/10.1038\/s41575-023-00840-w (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"45676_CR6","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.3748\/wjg.v27.i39.6527","volume":"27","author":"A Jain","year":"2021","unstructured":"Jain, A. & Bhardwaj, V. Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities. World J. Gastroenterol. 27, 6527\u20136550. https:\/\/doi.org\/10.3748\/wjg.v27.i39.6527 (2021).","journal-title":"World J. Gastroenterol."},{"key":"45676_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1470-2045(18)30136-0","volume":"19","author":"MR Howes","year":"2018","unstructured":"Howes, M. R. The evolution of anticancer drug discovery from plants. Lancet Oncol. 19, 293\u2013294. https:\/\/doi.org\/10.1016\/S1470-2045(18)30136-0 (2018).","journal-title":"Lancet Oncol."},{"key":"45676_CR8","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/j.jfda.2018.01.003","volume":"26","author":"YY Cheng","year":"2018","unstructured":"Cheng, Y. Y., Hsieh, C. H. & Tsai, T. H. Concurrent administration of anticancer chemotherapy drug and herbal medicine on the perspective of pharmacokinetics. J. Food Drug Anal. 26, S88\u2013S95. https:\/\/doi.org\/10.1016\/j.jfda.2018.01.003 (2018).","journal-title":"J. Food Drug Anal."},{"key":"45676_CR9","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.12659\/msm.904492","volume":"23","author":"L Hou","year":"2017","unstructured":"Hou, L., Chen, L. & Fang, L. Scutellarin inhibits proliferation, invasion, and tumorigenicity in human breast cancer cells by regulating HIPPO-YAP signaling pathway. Med. Sci. Monit. 23, 5130\u20135138. https:\/\/doi.org\/10.12659\/msm.904492 (2017).","journal-title":"Med. Sci. Monit."},{"key":"45676_CR10","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.3892\/ijmm.2018.3515","volume":"41","author":"X Zheng","year":"2018","unstructured":"Zheng, X., Kang, W., Liu, H. & Guo, S. Inhibition effects of total flavonoids from Sculellaria barbata D. Don on human breast carcinoma bone metastasis via downregulating PTHrP pathway. Int. J. Mol. Med. 41, 3137\u20133146. https:\/\/doi.org\/10.3892\/ijmm.2018.3515 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"45676_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tiv.2009.08.002","volume":"24","author":"Z Liu","year":"2010","unstructured":"Liu, Z., Liu, M., Liu, M. & Li, J. Methylanthraquinone from Hedyotis diffusa WILLD induces Ca(2+)-mediated apoptosis in human breast cancer cells. Toxicol. In Vitro 24, 142\u2013147. https:\/\/doi.org\/10.1016\/j.tiv.2009.08.002 (2010).","journal-title":"Toxicol. In Vitro"},{"key":"45676_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1055\/s-2000-8544","volume":"66","author":"CM Lu","year":"2000","unstructured":"Lu, C. M., Yang, J. J., Wang, P. Y. & Lin, C. C. A new acylated flavonol glycoside and antioxidant effects of Hedyotis diffusa. Planta Med. 66, 374\u2013377. https:\/\/doi.org\/10.1055\/s-2000-8544 (2000).","journal-title":"Planta Med."},{"key":"45676_CR13","first-page":"633","volume":"25","author":"CC Lin","year":"2011","unstructured":"Lin, C. C. et al. Extract of Hedyotis diffusa Willd influences murine leukemia WEHI-3 cells in vivo as well as promoting T- and B-cell proliferation in leukemic mice. Vivo 25, 633\u2013640 (2011).","journal-title":"Vivo"},{"key":"45676_CR14","doi-asserted-by":"publisher","first-page":"27252","DOI":"10.3390\/ijms161126021","volume":"16","author":"JH Ye","year":"2015","unstructured":"Ye, J. H., Liu, M. H., Zhang, X. L. & He, J. Y. Chemical profiles and protective effect of Hedyotis diffusa Willd in lipopolysaccharide-induced renal inflammation mice. Int. J. Mol. Sci. 16, 27252\u201327269. https:\/\/doi.org\/10.3390\/ijms161126021 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"45676_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/J157v04n01_03","volume":"4","author":"S Gupta","year":"2004","unstructured":"Gupta, S., Zhang, D., Yi, J. & Shao, J. Anticancer activities of Oldenlandia diffusa. J. Herb. Pharmacother. 4, 21\u201333 (2004).","journal-title":"J. Herb. Pharmacother."},{"key":"45676_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.607413","volume":"11","author":"CY Wang","year":"2020","unstructured":"Wang, C. Y. et al. Effect of Chinese herbal medicine therapy on overall and cancer related mortality in patients with advanced nasopharyngeal carcinoma in Taiwan. Front. Pharmacol. 11, 607413. https:\/\/doi.org\/10.3389\/fphar.2020.607413 (2020).","journal-title":"Front. Pharmacol."},{"key":"45676_CR17","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1080\/21691401.2019.1594862","volume":"47","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Green synthesis of gold nanoparticles from Scutellaria barbata and its anticancer activity in pancreatic cancer cell (PANC-1). Artif. Cells Nanomed. Biotechnol. 47, 1617\u20131627. https:\/\/doi.org\/10.1080\/21691401.2019.1594862 (2019).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"45676_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115516","volume":"297","author":"PW Yang","year":"2022","unstructured":"Yang, P. W. et al. Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer. J. Ethnopharmacol. 297, 115516. https:\/\/doi.org\/10.1016\/j.jep.2022.115516 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"45676_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1031051","volume":"13","author":"X Zhu","year":"2022","unstructured":"Zhu, X. et al. Multi-omics approaches for in-depth understanding of therapeutic mechanism for Traditional Chinese Medicine. Front. Pharmacol. 13, 1031051. https:\/\/doi.org\/10.3389\/fphar.2022.1031051 (2022).","journal-title":"Front. Pharmacol."},{"key":"45676_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155231","volume":"123","author":"S Lv","year":"2024","unstructured":"Lv, S. et al. Mechanisms of multi-omics and network pharmacology to explain Traditional Chinese Medicine for vascular cognitive impairment: A narrative review. Phytomedicine 123, 155231. https:\/\/doi.org\/10.1016\/j.phymed.2023.155231 (2024).","journal-title":"Phytomedicine"},{"key":"45676_CR21","doi-asserted-by":"publisher","DOI":"10.5740\/jaoacint.17-0469","author":"W Yang","year":"2018","unstructured":"Yang, W. et al. Simultaneous Determination of 15 Flavonoids in Scutellaria barbata-Hedyotis diffusa Herb Pair by HPLC Q-TOF MS. J. AOAC Int. https:\/\/doi.org\/10.5740\/jaoacint.17-0469 (2018).","journal-title":"J. AOAC Int."},{"key":"45676_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.joim.2024.10.001","volume":"22","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. A herbal pair of Scutellaria barbata D. Don and Scleromitrion diffusum (Willd.) R.J. Wang induced ferroptosis in ovarian cancer A2780 cells via inducing heme catabolism and ferritinophagy. J. Integr. Med. 22, 665\u2013682. https:\/\/doi.org\/10.1016\/j.joim.2024.10.001 (2024).","journal-title":"J. Integr. Med."},{"key":"45676_CR23","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1016\/j.apsb.2025.05.024","volume":"15","author":"L Xia","year":"2025","unstructured":"Xia, L. et al. Unveiling the renoprotective mechanisms of self-assembled herbal nanoparticles from Scutellaria barbata and Scleromitrion diffusum in acute kidney injury: A nano-TCM approach. Acta Pharm. Sin. B 15, 4265\u20134284. https:\/\/doi.org\/10.1016\/j.apsb.2025.05.024 (2025).","journal-title":"Acta Pharm. Sin. B"},{"key":"45676_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jep.2013.10.067","volume":"151","author":"Y Li","year":"2014","unstructured":"Li, Y. et al. Investigation into the mechanism of Eucommia ulmoides Oliv. based on a systems pharmacology approach. J. Ethnopharmacol. 151, 452\u2013460. https:\/\/doi.org\/10.1016\/j.jep.2013.10.067 (2014).","journal-title":"J. Ethnopharmacol."},{"key":"45676_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-016-0130-x","volume":"8","author":"Z Wang","year":"2016","unstructured":"Wang, Z., Liang, L., Yin, Z. & Lin, J. Improving chemical similarity ensemble approach in target prediction. J. Cheminform. 8, 20. https:\/\/doi.org\/10.1186\/s13321-016-0130-x (2016).","journal-title":"J. Cheminform."},{"key":"45676_CR26","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364. https:\/\/doi.org\/10.1093\/nar\/gkz382 (2019).","journal-title":"Nucleic Acids Res."},{"key":"45676_CR27","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 52, D1465\u2013D1477. https:\/\/doi.org\/10.1093\/nar\/gkad751 (2024).","journal-title":"Nucleic Acids Res."},{"key":"45676_CR28","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037 (2018).","journal-title":"Nucleic Acids Res."},{"key":"45676_CR29","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero, J. et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 48, D845\u2013D855. https:\/\/doi.org\/10.1093\/nar\/gkz1021 (2020).","journal-title":"Nucleic Acids Res."},{"key":"45676_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"45676_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6 (2019).","journal-title":"Nat. Commun."},{"key":"45676_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112526","volume":"251","author":"SST Hnit","year":"2020","unstructured":"Hnit, S. S. T. et al. Transcriptional regulation of G(2)\/M regulatory proteins and perturbation of G(2)\/M cell cycle transition by a traditional Chinese medicine recipe. J. Ethnopharmacol. 251, 112526. https:\/\/doi.org\/10.1016\/j.jep.2019.112526 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"45676_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114110","volume":"275","author":"PW Yang","year":"2021","unstructured":"Yang, P. W. et al. Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit Hepatitis B virus-associated hepatocellular carcinoma growth through regulating circRNA expression. J. Ethnopharmacol. 275, 114110. https:\/\/doi.org\/10.1016\/j.jep.2021.114110 (2021).","journal-title":"J. Ethnopharmacol."},{"key":"45676_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1006131","volume":"12","author":"J Shi","year":"2022","unstructured":"Shi, J. et al. JNK inhibitor IX restrains pancreatic cancer through p53 and p21. Front. Oncol. 12, 1006131. https:\/\/doi.org\/10.3389\/fonc.2022.1006131 (2022).","journal-title":"Front. Oncol."},{"key":"45676_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1091\/mbc.e07-06-0525","volume":"19","author":"A Satyanarayana","year":"2008","unstructured":"Satyanarayana, A., Hilton, M. B. & Kaldis, P. p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1\/S phase DNA damage checkpoint. Mol. Biol. Cell 19, 65\u201377. https:\/\/doi.org\/10.1091\/mbc.e07-06-0525 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"45676_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3724\/abbs.2024138","volume":"57","author":"B Liu","year":"2024","unstructured":"Liu, B. et al. Hsp90alpha promotes chemoresistance in pancreatic cancer by regulating Keap1-Nrf2 axis and inhibiting ferroptosis. Acta Biochim. Biophys. Sin. 57, 295\u2013309. https:\/\/doi.org\/10.3724\/abbs.2024138 (2024).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"45676_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103586","author":"YD Choi","year":"2020","unstructured":"Choi, Y. D. et al. APE1 promotes pancreatic cancer proliferation through GFR\u03b11\/Src\/ERK axis-cascade signaling in response to GDNF. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21103586 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"45676_CR38","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo, Y. J. et al. ERK\/MAPK signalling pathway and tumorigenesis. Exp. Ther. Med. 19, 1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454 (2020).","journal-title":"Exp. Ther. Med."},{"key":"45676_CR39","doi-asserted-by":"publisher","first-page":"688","DOI":"10.20892\/j.issn.2095-3941.2019.0252","volume":"16","author":"F Quinonero","year":"2019","unstructured":"Quinonero, F. et al. The challenge of drug resistance in pancreatic ductal adenocarcinoma: A current overview. Cancer Biol. Med. 16, 688\u2013699. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2019.0252 (2019).","journal-title":"Cancer Biol. Med."},{"key":"45676_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17697-1","volume":"11","author":"E Montaudon","year":"2020","unstructured":"Montaudon, E. et al. PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance. Nat. Commun. 11, 4053. https:\/\/doi.org\/10.1038\/s41467-020-17697-1 (2020).","journal-title":"Nat. Commun."},{"key":"45676_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s12276-021-00635-6","volume":"53","author":"PK Mou","year":"2021","unstructured":"Mou, P. K. et al. Aurora kinase A, a synthetic lethal target for precision cancer medicine. Exp. Mol. Med. 53, 835\u2013847. https:\/\/doi.org\/10.1038\/s12276-021-00635-6 (2021).","journal-title":"Exp. Mol. Med."},{"key":"45676_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/sji.12442","volume":"84","author":"D Jia","year":"2016","unstructured":"Jia, D. et al. Investigation on immunomodulatory activity of calf spleen extractive injection in cyclophosphamide-induced immunosuppressed mice and underlying mechanisms. Scand. J. Immunol. 84, 20\u201327. https:\/\/doi.org\/10.1111\/sji.12442 (2016).","journal-title":"Scand. J. Immunol."},{"key":"45676_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.fm.2019.103343","volume":"86","author":"Q Li","year":"2020","unstructured":"Li, Q., Tao, Q., Teixeira, J. S., Su, S.-W.M. & Ganzle, M. G. Contribution of glutaminases to glutamine metabolism and acid resistance in Lactobacillus reuteri and other vertebrate host adapted lactobacilli. Food Microbiol. 86, 103343. https:\/\/doi.org\/10.1016\/j.fm.2019.103343 (2020).","journal-title":"Food Microbiol."},{"key":"45676_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","volume":"67","author":"F Imhann","year":"2018","unstructured":"Imhann, F. et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67, 108\u2013119. https:\/\/doi.org\/10.1136\/gutjnl-2016-312135 (2018).","journal-title":"Gut"},{"key":"45676_CR45","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","volume":"71","author":"E Kartal","year":"2022","unstructured":"Kartal, E. et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut 71, 1359\u20131372. https:\/\/doi.org\/10.1136\/gutjnl-2021-324755 (2022).","journal-title":"Gut"},{"key":"45676_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59\u201364. https:\/\/doi.org\/10.1038\/nature13568 (2014).","journal-title":"Nature"},{"key":"45676_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42997-7","volume":"14","author":"R Liu","year":"2023","unstructured":"Liu, R. et al. Gut microbial structural variation associates with immune checkpoint inhibitor response. Nat. Commun. 14, 7421. https:\/\/doi.org\/10.1038\/s41467-023-42997-7 (2023).","journal-title":"Nat. Commun."},{"key":"45676_CR48","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: A phase I trial. Nat. Med. 29, 2121\u20132132. https:\/\/doi.org\/10.1038\/s41591-023-02453-x (2023).","journal-title":"Nat. Med."},{"key":"45676_CR49","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.ijbiomac.2021.05.056","volume":"182","author":"AA Gamal","year":"2021","unstructured":"Gamal, A. A. et al. Optimization strategy of Bacillus subtilis MT453867 levansucrase and evaluation of levan role in pancreatic cancer treatment. Int. J. Biol. Macromol. 182, 1590\u20131601. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.05.056 (2021).","journal-title":"Int. J. Biol. Macromol."},{"key":"45676_CR50","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.carbpol.2012.02.041","volume":"89","author":"AM Abdel-Fattah","year":"2012","unstructured":"Abdel-Fattah, A. M., Gamal-Eldeen, A. M., Helmy, W. A. & Esawy, M. A. Antitumor and antioxidant activities of levan and its derivative from the isolate Bacillus subtilis NRC1aza. Carbohydr. Polym. 89, 314\u2013322. https:\/\/doi.org\/10.1016\/j.carbpol.2012.02.041 (2012).","journal-title":"Carbohydr. Polym."},{"key":"45676_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173531","author":"S Hata","year":"2022","unstructured":"Hata, S. et al. Gut microbiota changes by an SGLT2 inhibitor, Luseogliflozin, alters metabolites compared with those in a low carbohydrate diet in db\/db mice. Nutrients https:\/\/doi.org\/10.3390\/nu14173531 (2022).","journal-title":"Nutrients"},{"key":"45676_CR52","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1038\/s41396-022-01287-8","volume":"16","author":"Y Jing","year":"2022","unstructured":"Jing, Y. et al. Amino acid utilization allows intestinal dominance of Lactobacillus amylovorus. ISME J. 16, 2491\u20132502. https:\/\/doi.org\/10.1038\/s41396-022-01287-8 (2022).","journal-title":"ISME J."},{"key":"45676_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1148166","volume":"14","author":"U Kansakar","year":"2023","unstructured":"Kansakar, U. et al. Choline supplements: An update. Front Endocrinol (Lausanne) 14, 1148166. https:\/\/doi.org\/10.3389\/fendo.2023.1148166 (2023).","journal-title":"Front Endocrinol (Lausanne)"},{"key":"45676_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155190","author":"K Hirai","year":"2020","unstructured":"Hirai, K. et al. Molecular and functional analysis of choline transporters and antitumor effects of choline transporter-like protein 1 inhibitors in human pancreatic cancer cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21155190 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"45676_CR55","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1080\/15384101.2014.998085","volume":"14","author":"N Bendris","year":"2015","unstructured":"Bendris, N., Lemmers, B. & Blanchard, J. M. Cell cycle, cytoskeleton dynamics and beyond: The many functions of cyclins and CDK inhibitors. Cell Cycle 14, 1786\u20131798. https:\/\/doi.org\/10.1080\/15384101.2014.998085 (2015).","journal-title":"Cell Cycle"},{"key":"45676_CR56","first-page":"4050","volume":"11","author":"P Gibieza","year":"2021","unstructured":"Gibieza, P. & Petrikaite, V. The regulation of actin dynamics during cell division and malignancy. Am. J. Cancer Res. 11, 4050\u20134069 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"45676_CR57","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.biocel.2010.04.007","volume":"42","author":"YW Heng","year":"2010","unstructured":"Heng, Y. W. & Koh, C. G. Actin cytoskeleton dynamics and the cell division cycle. Int. J. Biochem. Cell Biol. 42, 1622\u20131633. https:\/\/doi.org\/10.1016\/j.biocel.2010.04.007 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"45676_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112613","volume":"403","author":"BS Swaroop","year":"2021","unstructured":"Swaroop, B. S. et al. KIBRA connects Hippo signaling and cancer. Exp. Cell Res. 403, 112613. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112613 (2021).","journal-title":"Exp. Cell Res."},{"key":"45676_CR59","doi-asserted-by":"publisher","first-page":"9423","DOI":"10.1073\/pnas.1821370116","volume":"116","author":"W Kim","year":"2019","unstructured":"Kim, W. et al. Hippo signaling is intrinsically regulated during cell cycle progression by APC\/C(Cdh1). Proc. Natl. Acad. Sci. U. S. A. 116, 9423\u20139432. https:\/\/doi.org\/10.1073\/pnas.1821370116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"45676_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3691635","volume":"2022","author":"H Li","year":"2022","unstructured":"Li, H. et al. BCKDK promotes ovarian cancer proliferation and migration by activating the MEK\/ERK signaling pathway. J. Oncol. 2022, 3691635. https:\/\/doi.org\/10.1155\/2022\/3691635 (2022).","journal-title":"J. Oncol."},{"key":"45676_CR61","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ebiom.2017.05.001","volume":"20","author":"P Xue","year":"2017","unstructured":"Xue, P. et al. BCKDK of BCAA catabolism cross-talking with the MAPK pathway promotes tumorigenesis of colorectal cancer. EBioMedicine 20, 50\u201360. https:\/\/doi.org\/10.1016\/j.ebiom.2017.05.001 (2017).","journal-title":"EBioMedicine"},{"key":"45676_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2610-1","volume":"11","author":"M Zhai","year":"2020","unstructured":"Zhai, M. et al. APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway. Cell Death Dis. 11, 396. https:\/\/doi.org\/10.1038\/s41419-020-2610-1 (2020).","journal-title":"Cell Death Dis."},{"key":"45676_CR63","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmet.2021.01.018","volume":"33","author":"OA Maguire","year":"2021","unstructured":"Maguire, O. A. et al. Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer. Cell Metab. 33, 499-512 e496. https:\/\/doi.org\/10.1016\/j.cmet.2021.01.018 (2021).","journal-title":"Cell Metab."},{"key":"45676_CR64","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bbamcr.2016.01.015","volume":"1863","author":"F Kopp","year":"2016","unstructured":"Kopp, F., Kupsch, S. & Schromm, A. B. Lipopolysaccharide-binding protein is bound and internalized by host cells and colocalizes with LPS in the cytoplasm: Implications for a role of LBP in intracellular LPS-signaling. Biochim. Biophys. Acta 1863, 660\u2013672. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.015 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"45676_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22864-z","volume":"12","author":"J Zuo","year":"2022","unstructured":"Zuo, J. et al. A novel refined pyroptosis and inflammasome-related genes signature for predicting prognosis and immune microenvironment in pancreatic ductal adenocarcinoma. Sci. Rep. 12, 18384. https:\/\/doi.org\/10.1038\/s41598-022-22864-z (2022).","journal-title":"Sci. Rep."},{"key":"45676_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02230-z","volume":"41","author":"H Li","year":"2022","unstructured":"Li, H. et al. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells. J. Exp. Clin. Cancer Res. 41, 33. https:\/\/doi.org\/10.1186\/s13046-021-02230-z (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"45676_CR67","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.3892\/ol.2019.10765","volume":"18","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Identification of potential diagnostic and prognostic biomarkers for prostate cancer. Oncol. Lett. 18, 4237\u20134245. https:\/\/doi.org\/10.3892\/ol.2019.10765 (2019).","journal-title":"Oncol. Lett."},{"key":"45676_CR68","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1097\/JS9.0000000000001724","volume":"110","author":"J Hong","year":"2024","unstructured":"Hong, J. et al. Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: A systematic review and meta-analysis. Int. J. Surg. 110, 5781\u20135794. https:\/\/doi.org\/10.1097\/JS9.0000000000001724 (2024).","journal-title":"Int. J. Surg."},{"key":"45676_CR69","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1158\/1078-0432.CCR-14-0964","volume":"21","author":"MF Penet","year":"2015","unstructured":"Penet, M. F. et al. Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism. Clin. Cancer Res. 21, 386\u2013395. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0964 (2015).","journal-title":"Clin. Cancer Res."},{"key":"45676_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107364","volume":"208","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. Decoding the microbiota metabolome in hepatobiliary and pancreatic cancers: Pathways to precision diagnostics and targeted therapeutics. Pharmacol. Res. 208, 107364. https:\/\/doi.org\/10.1016\/j.phrs.2024.107364 (2024).","journal-title":"Pharmacol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45676-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:34:55Z","timestamp":1774953295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45676-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45676"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45676-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experimental procedures were approved by the Animal Ethics Committee of Dalian Medical University (Approval No: AEE21052) and were conducted in accordance with the relevant institutional, national, and international guidelines for the care and use of laboratory animals. This study is reported in accordance with the ARRIVE guidelines. The maximal tumor burden permitted in this study was defined as 1500 mm\n                      3\n                      , and no tumor in any experimental subject exceeded this threshold. Humane endpoints were implemented to ensure animal welfare. Mice were euthanized via cervical dislocation under anesthesia (isoflurane inhalation) when tumors approached the size limit.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"10866"}}